Vanda Pharmaceuticals Inc.·4

Mar 5, 5:19 PM ET

Polymeropoulos Mihael Hristos 4

4 · Vanda Pharmaceuticals Inc. · Filed Mar 5, 2025

Insider Transaction Report

Form 4
Period: 2025-03-05
Polymeropoulos Mihael Hristos
DirectorPresident and CEOOther
Transactions
  • Purchase

    Common Stock

    2025-03-05$5.01/sh+5,000$25,0502,280,731 total
  • Purchase

    Common Stock

    2025-03-05$5.03/sh+5,000$25,1502,285,731 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4